市场调查报告书
商品编码
1372449
心臟假体设备市场 - 按产品(心臟瓣膜、起搏器)、最终用途(医院、门诊手术中心)和预测,2023 - 2032 年Cardiac Prosthetic Devices Market - By Product (Heart Valves, Pacemaker), By End-use (Hospitals, Ambulatory Surgical Centers), & Forecast, 2023 - 2032 |
2023年至2032年,心臟假体器械市场规模将以8.4%的复合年增长率增长。心血管疾病患病率的上升和人口的迅速老化正在对全球心臟干预产生强劲的需求。微创手术和改进材料等技术进步的激增也提高了心臟假体设备的功效和安全性,进一步推动了产业扩张。例如,2022 年9 月,美敦力(Medtronic) 在美国推出了其最新版本的自膨胀式经导管主动脉瓣置换(TAVR) 系统Evolut (TM) FX TAVR 系统,以提高易用性并为医生提供更多服务可预测的阀门部署。
此外,医疗保健支出和保险覆盖范围的增加也增加了患者获得心臟假体设备的机会。此外,人们对心臟健康的认识不断增强以及对更高生活品质的追求将推动业务成长。
市场根据产品、最终用途和地区进行分类。
从产品来看,心臟瓣膜领域的心臟假体器械产业在 2023 年至 2032 年期间将以 8.8% 的复合年增长率成长。瓣膜性心臟病病例的增加正在导致心臟瓣膜修復技术的进步。人口老化的加剧也将推动人们对创新和耐用的心臟瓣膜产品的偏好。
就最终用途而言,到 2032 年,门诊手术中心领域的复合年增长率将达到 8.8%。这一增长是由对门诊心臟手术的日益偏好所推动的。成本效益、减少住院时间和提高医疗保健可近性等优势也将增加对门诊手术中心作为心臟介入治疗首选的需求。
从地区来看,在不断发展的医疗基础设施、不断增加的医疗支出和人口老化的推动下,欧洲心臟假体器材产业到 2032 年将以 8.1% 的复合年增长率增长。此外,心臟健康意识的提高和医疗技术的进步将有利于区域市场的成长。此外,微创手术技术和创新材料等医疗技术的不断进步正在提高心臟手术的品质和成功率,使心臟假体装置对欧洲地区的患者更加有效和有吸引力。
Cardiac prosthetic devices market size will grow at 8.4% CAGR from 2023 to 2032. The rising prevalence of cardiovascular diseases and the rapidly aging population is creating a strong demand for cardiac interventions worldwide. The surge in technological advancements, such as minimally invasive procedures and improved materials is also enhancing the efficacy and safety of cardiac prosthetic devices, further driving the industry expansion. For instance, in September 2022, Medtronic unveiled the broader availability of its latest iteration of self-expanding transcatheter aortic valve replacement (TAVR) systems in the U.S., the Evolut™ FX TAVR system to improve ease of use and provide physicians with more predictable valve deployment.
Additionally, the increased healthcare spending and insurance coverage is increasing patient access to cardiac prosthetic devices. Furthermore, the growing awareness of heart health and the pursuit of higher quality of life will fuel the business growth.
The market is categorized based on product, end-use, and region.
Based on product, the cardiac prosthetic devices industry from the heart valves segment will grow at an 8.8% CAGR during 2023-2032. The increasing cases of valvular heart diseases is leading to the technological advancements in heart valve prosthetics. The growing aging population will also drive the preference for innovative and durable heart valve products.
With respect to end-use, the ambulatory surgical centers segment will exhibit an 8.8% CAGR through 2032. The growth is driven by the rising preference for outpatient cardiac procedures. Advantages, such as cost-efficiency, reduced hospitalization time, and increased healthcare accessibility will also contribute to the demand for ambulatory surgical centers as favored choice for cardiac interventions.
Regionally, the Europe cardiac prosthetic devices industry will grow at 8.1% CAGR through 2032, driven by evolving healthcare infrastructure, increasing healthcare expenditure, and the growing aging population. Moreover, the rising awareness of heart health and advancements in medical technologies will favor the regional market growth. In addition, the growing advancements in medical technology, such as minimally invasive surgical techniques and innovative materials, are improving the quality and success of cardiac procedures, making the cardiac prosthetic devices more effective and attractive to patients in the European region.